05.08.2014 13:28 Uhr, Quelle: Wallstreet online

NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine

AMES, IA--(Marketwired - Aug 5, 2014) - NewLink Genetics Corporation (NASDAQ: NLNK), through its wholly owned subsidiary, BioProtection Systems Corporation (BPS), today announced a letter contract with the United States Defense Threat Reduction …

Weiterlesen bei Wallstreet online